GFA
8783
Chiome Bioscience
4583
Pluszero
5132
Pixel
2743
GreenBee
3913
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 42.74%13.08B | 19.07%53.4B | 55.45%20.09B | 11.86%12.68B | 3.16%11.47B | -3.28%9.16B | -2.35%44.85B | -1.48%12.93B | -6.89%11.33B | 1.17%11.11B |
Cost of revenue | 38.67%11.05B | 17.74%44.52B | 59.49%16.26B | 9.73%10.62B | -0.49%9.68B | -3.04%7.97B | -3.00%37.82B | -6.45%10.19B | -6.79%9.68B | 2.31%9.72B |
Gross profit | 69.82%2.03B | 26.23%8.87B | 40.42%3.84B | 24.26%2.05B | 28.80%1.79B | -4.85%1.2B | 1.25%7.03B | 22.80%2.73B | -7.45%1.65B | -6.28%1.39B |
Operating expense | 14.83%1.55B | 16.61%5.45B | 35.16%1.38B | 9.92%1.44B | 14.45%1.28B | 10.21%1.35B | 23.46%4.67B | 26.26%1.02B | 37.13%1.31B | 19.27%1.11B |
Operating profit | 415.03%482M | 45.31%3.43B | 43.59%2.45B | 79.24%613M | 86.91%514M | -563.64%-153M | -25.36%2.36B | 20.81%1.71B | -58.80%342M | -49.82%275M |
Net non-operating interest income (expenses) | -1M | -1M | -1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non-operating interest expense | --1M | --1M | --1M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Net investment income | 12.50%27M | 3M | 6.67%16M | 9.09%24M | ||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 202.50%82M | -1,485.71%-111M | 85.71%-1M | -5,650.00%-111M | 4,150.00%81M | -80M | 41.67%-7M | -7M | 150.00%2M | -115.38%-2M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -4M | -276.00%-94M | -3,200.00%-93M | 1,136.36%114M | -115M | 0 | -8.70%-25M | 250.00%3M | -1,200.00%-11M | 0 |
Less:Other special charges | --1M | 276.00%94M | 3,200.00%93M | -1,136.36%-114M | ---- | ---- | 933.33%25M | -200.00%-3M | 1,200.00%11M | --0 |
Less:Write off | --3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 53.19%72M | 29.53%193M | 138.46%31M | 58.70%73M | -22.22%42M | 30.56%47M | 0.68%149M | -31.58%13M | 4.55%46M | 3.85%54M |
Income before tax | 473.37%631M | 37.67%3.44B | 38.77%2.42B | 76.98%669M | 67.09%523M | -356.06%-169M | -24.10%2.5B | 19.99%1.74B | -56.60%378M | -46.40%313M |
Income tax | 853.13%241M | 41.38%1.23B | 42.31%787M | 63.48%291M | 70.37%184M | -203.23%-32M | -16.75%870M | 22.62%553M | -34.07%178M | -44.90%108M |
Net income | 384.67%390M | 35.69%2.21B | 37.21%1.63B | 88.50%377M | 65.37%339M | -491.43%-137M | -27.52%1.63B | 18.80%1.19B | -66.78%200M | -47.16%205M |
Net income continuous operations | 384.67%390M | 35.69%2.21B | 37.12%1.63B | 89.00%378M | 65.37%339M | -491.43%-137M | -27.52%1.63B | 18.80%1.19B | -66.72%200M | -47.16%205M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 384.67%390M | 35.69%2.21B | 37.21%1.63B | 88.50%377M | 65.37%339M | -491.43%-137M | -27.52%1.63B | 18.80%1.19B | -66.78%200M | -47.16%205M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 384.67%390M | 35.69%2.21B | 37.21%1.63B | 88.50%377M | 65.37%339M | -491.43%-137M | -27.52%1.63B | 18.80%1.19B | -66.78%200M | -47.16%205M |
Gross dividend payment | ||||||||||
Basic earnings per share | 383.91%13.94 | 35.67%78.92 | 37.15%58.22 | 88.38%13.45 | 66.12%12.16 | -489.68%-4.91 | -27.51%58.17 | 18.81%42.45 | -66.76%7.14 | -47.19%7.32 |
Diluted earnings per share | 383.91%13.94 | 35.67%78.92 | 37.17%58.22 | 88.38%13.45 | 65.45%12.111 | -489.68%-4.91 | -27.51%58.17 | 18.80%42.4422 | -66.76%7.14 | -47.19%7.32 |
Dividend per share | 0 | 11.11%40 | -15.38%22 | 0 | 80.00%18 | 0 | 27.06%36 | 30.00%26 | 0 | 20.00%10 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |